BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28712126)

  • 1. Evidence of an abnormal epithelial barrier in active, untreated and corticosteroid-treated eosinophilic esophagitis.
    Simon D; Page B; Vogel M; Bussmann C; Blanchard C; Straumann A; Simon HU
    Allergy; 2018 Jan; 73(1):239-247. PubMed ID: 28712126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active eosinophilic esophagitis is characterized by epithelial barrier defects and eosinophil extracellular trap formation.
    Simon D; Radonjic-Hösli S; Straumann A; Yousefi S; Simon HU
    Allergy; 2015 Apr; 70(4):443-52. PubMed ID: 25620273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent sensitization to Candida albicans and profilins in adult eosinophilic esophagitis.
    Simon D; Straumann A; Dahinden C; Simon HU
    Allergy; 2013 Jul; 68(7):945-8. PubMed ID: 23735202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice.
    Arias Á; Lucendo AJ
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):99-117. PubMed ID: 30791784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of topical steroids on tight junction proteins and spongiosis in esophageal epithelia of patients with eosinophilic esophagitis.
    Katzka DA; Tadi R; Smyrk TC; Katarya E; Sharma A; Geno DM; Camilleri M; Iyer PG; Alexander JA; Buttar NS
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1824-9.e1. PubMed ID: 24681080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.
    Kagalwalla AF; Akhtar N; Woodruff SA; Rea BA; Masterson JC; Mukkada V; Parashette KR; Du J; Fillon S; Protheroe CA; Lee JJ; Amsden K; Melin-Aldana H; Capocelli KE; Furuta GT; Ackerman SJ
    J Allergy Clin Immunol; 2012 May; 129(5):1387-1396.e7. PubMed ID: 22465212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE).
    Chandramouleeswaran PM; Shen D; Lee AJ; Benitez A; Dods K; Gambanga F; Wilkins BJ; Merves J; Noah Y; Toltzis S; Yearley JH; Spergel JM; Nakagawa H; Malefyt Rd; Muir AB; Wang ML
    PLoS One; 2016; 11(3):e0150968. PubMed ID: 26992000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis.
    McNamee EN; Biette KA; Hammer J; Harris R; Miyazawa H; Lee JJ; Furuta GT; Masterson JC
    Allergy; 2017 Aug; 72(8):1232-1242. PubMed ID: 27926989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE.
    Clayton F; Fang JC; Gleich GJ; Lucendo AJ; Olalla JM; Vinson LA; Lowichik A; Chen X; Emerson L; Cox K; O'Gorman MA; Peterson KA
    Gastroenterology; 2014 Sep; 147(3):602-9. PubMed ID: 24907494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivity.
    Simon D; Cianferoni A; Spergel JM; Aceves S; Holbreich M; Venter C; Rothenberg ME; Terreehorst I; Muraro A; Lucendo AJ; Schoepfer A; Straumann A; Simon HU
    Allergy; 2016 May; 71(5):611-20. PubMed ID: 26799684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning-based identification and characterization of mast cells in eosinophilic esophagitis.
    Zhang S; Caldwell JM; Rochman M; Collins MH; Rothenberg ME
    J Allergy Clin Immunol; 2024 May; 153(5):1381-1391.e6. PubMed ID: 38395083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rate of galactose-alpha-1,3-galactose sensitization in both eosinophilic esophagitis and patients undergoing upper endoscopy.
    Burk CM; Beitia R; Lund PK; Dellon ES
    Dis Esophagus; 2016 Aug; 29(6):558-62. PubMed ID: 25809945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis.
    Rieder F; Nonevski I; Ma J; Ouyang Z; West G; Protheroe C; DePetris G; Schirbel A; Lapinski J; Goldblum J; Bonfield T; Lopez R; Harnett K; Lee J; Hirano I; Falk G; Biancani P; Fiocchi C
    Gastroenterology; 2014 May; 146(5):1266-77.e1-9. PubMed ID: 24486052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological Response to Fluticasone Propionate in Patients With Eosinophilic Esophagitis Is Associated With Improved Functional Esophageal Mucosal Integrity.
    van Rhijn BD; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
    Am J Gastroenterol; 2015 Sep; 110(9):1289-97. PubMed ID: 26303134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atopic and non-atopic eosinophilic oesophagitis are distinguished by immunoglobulin E-bearing intraepithelial mast cells.
    Mulder DJ; Mak N; Hurlbut DJ; Justinich CJ
    Histopathology; 2012 Nov; 61(5):810-22. PubMed ID: 22978418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis.
    Noti M; Wojno ED; Kim BS; Siracusa MC; Giacomin PR; Nair MG; Benitez AJ; Ruymann KR; Muir AB; Hill DA; Chikwava KR; Moghaddam AE; Sattentau QJ; Alex A; Zhou C; Yearley JH; Menard-Katcher P; Kubo M; Obata-Ninomiya K; Karasuyama H; Comeau MR; Brown-Whitehorn T; de Waal Malefyt R; Sleiman PM; Hakonarson H; Cianferoni A; Falk GW; Wang ML; Spergel JM; Artis D
    Nat Med; 2013 Aug; 19(8):1005-13. PubMed ID: 23872715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered esophageal histamine receptor expression in Eosinophilic Esophagitis (EoE): implications on disease pathogenesis.
    Merves J; Chandramouleeswaran PM; Benitez AJ; Muir AB; Lee AJ; Lim DM; Dods K; Mehta I; Ruchelli ED; Nakagawa H; Spergel JM; Wang ML
    PLoS One; 2015; 10(2):e0114831. PubMed ID: 25723478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-related apoptosis-inducing ligand (TRAIL) regulates midline-1, thymic stromal lymphopoietin, inflammation, and remodeling in experimental eosinophilic esophagitis.
    Collison AM; Sokulsky LA; Sherrill JD; Nightingale S; Hatchwell L; Talley NJ; Walker MM; Rothenberg ME; Mattes J
    J Allergy Clin Immunol; 2015 Oct; 136(4):971-82. PubMed ID: 25981737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic and gene expression analysis of initial biopsies from patients with eosinophilic esophagitis refractory to therapy.
    Siddique AS; Corney DC; Mangray S; Lombardo KA; Chen S; Marwaha AS; Resnick MB; Herzlinger M; Matoso A
    Hum Pathol; 2017 Oct; 68():79-86. PubMed ID: 28882697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical differentiation of eosinophilic esophageal myositis from eosinophilic esophagitis.
    Sato H; Nakajima N; Hasegawa G; Kawata Y; Sato Y; Suzuki K; Honma T; Terai S
    J Gastroenterol Hepatol; 2017 Jan; 32(1):106-113. PubMed ID: 27262491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.